John Sanderson, M.D.

CEO, XOStem, Irvine, CA

Dr. Sanderson is a physician-scientist with a focus on regenerative medicine. He began his career in clinical medicine, specializing in diabetes and IV nutrition. As an NIH-supported scholar and multiple grant recipient, he created a number of new products and systems for treatment of aging and chronic diseases. As medical director at Johnson & Johnson, he participated in diabetes research on an international scale. In recent years Dr. Sanderson has created several enterprises focused on the application of mesenchymal stem cells and exosomes to problems of diabetes, gerontology, dermatology, gynecology, and aesthetics. Dr. Sanderson is CEO of XOStem Inc, a regenerative medicine collaboration with the University of California at Irvine, currently in clinical trials with an encapsulated stem cell transplant for diabetes, and CEO & Chief Scientist at Cellese Regenerative Therapeutics, the creators of AnteAGE MD and AnteAGE brand products, and serves as Chief Science Officer for several public companies including Lifestyle Delivery Systems, and CellMedX.